REFERENCES:
Abdallah, H., Wintermans, B., Reuland, E., Koek, A., Al Naiemi, N.,
Ammar, A., . . . Vandenbroucke-Grauls, C. (2015). Extended-spectrum
β-lactamase-and carbapenemase-producing Enterobacteriaceae isolated from
egyptian patients with suspected blood stream infection. PloS one,
10 (5), e0128120.
Abe, R., Oda, S., Sadahiro, T., Nakamura, M., Hirayama, Y., Tateishi,
Y., . . . Hirasawa, H. (2010). Gram-negative bacteremia induces greater
magnitude of inflammatory response than Gram-positive bacteremia.Critical Care, 14 (2), 1-7.
Al-Agamy, M. H., Shibl, A. M., & Tawfik, A. F. (2009). Prevalence and
molecular characterization of extended-spectrum β-lactamase-producing
Klebsiella pneumoniae in Riyadh, Saudi Arabia. Annals of Saudi
medicine, 29 (4), 253.
Amer, W. H., Khalil, H. S., & Abd EL Wahab, M. (2016). Risk factors,
phenotypic and genotypic characterization of carbapenem resistant
Enterobacteriaceae in Tanta University Hospitals, Egypt. Int J
Infect Control, 12 (2), 1-11.
America, I. D. S. o. (2011). Combating antimicrobial resistance: policy
recommendations to save lives. Clinical Infectious Diseases,
52 (suppl_5), S397-S428.
Bassetti, M., Merelli, M., Temperoni, C., & Astilean, A. (2013). New
antibiotics for bad bugs: where are we? Annals of Clinical
Microbiology and Antimicrobials, 12 (1), 22. doi:10.1186/1476-0711-12-22
Bauer, A. (1966). Antibiotic susceptibility testing by a standardized
single disc method. Am J clin pathol, 45 , 149-158.
Bell, B. G., Schellevis, F., Stobberingh, E., Goossens, H., & Pringle,
M. (2014). A systematic review and meta-analysis of the effects of
antibiotic consumption on antibiotic resistance. BMC infectious
diseases, 14 (1), 13.
Bookstaver, P., Nimmich, E., Smith, T., Justo, J., Kohn, J., Hammer, K.,
. . . Al-Hasan, M. (2017). Cumulative effect of an antimicrobial
stewardship and rapid diagnostic testing bundle on early streamlining of
antimicrobial therapy in gram-negative bloodstream infections.Antimicrobial agents and chemotherapy, 61 (9), e00189-00117.
Buising, K., Thursky, K., Robertson, M., Black, J., Street, A.,
Richards, M., & Brown, G. (2008). Electronic antibiotic
stewardship—reduced consumption of broad-spectrum antibiotics using a
computerized antimicrobial approval system in a hospital setting.Journal of Antimicrobial Chemotherapy, 62 (3), 608-616.
Cantón, R., Horcajada, J. P., Oliver, A., Garbajosa, P. R., & Vila, J.
(2013). Inappropriate use of antibiotics in hospitals: the complex
relationship between antibiotic use and antimicrobial resistance.Enfermedades infecciosas y microbiologia clinica, 31 , 3-11.
Conway, E. L., Sellick, J. A., Horey, A., Fodero, K., Ott, M. C.,
Krajewski, M. P., & Mergenhagen, K. A. (2017). Decreased mortality in
patients prescribed vancomycin after implementation of antimicrobial
stewardship program. American journal of infection control,
45 (11), 1194-1197.
Costelloe, C., Metcalfe, C., Lovering, A., Mant, D., & Hay, A. D.
(2010). Effect of antibiotic prescribing in primary care on
antimicrobial resistance in individual patients: systematic review and
meta-analysis. Bmj, 340 .
Davey, P., Brown, E., Charani, E., Fenelon, L., Gould, I. M., Holmes,
A., . . . Wilcox, M. (2013). Interventions to improve antibiotic
prescribing practices for hospital inpatients. Cochrane Database
of Systematic Reviews (4).
Dellit, T. H., Owens, R. C., McGowan, J. E., Gerding, D. N., Weinstein,
R. A., Burke, J. P., . . . Carpenter, C. F. (2007). Infectious Diseases
Society of America and the Society for Healthcare Epidemiology of
America guidelines for developing an institutional program to enhance
antimicrobial stewardship. Clinical Infectious Diseases, 44 (2),
159-177.
Doane, D. P., & Seward, L. E. (2011). Measuring skewness: a forgotten
statistic? Journal of statistics education, 19 (2).
El Kholy, A., & El Manakhly, A. (2018). 2300. Molecular
Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae (CRKP)
Causing Central Line Associated Blood Stream Infections (CLABSI) in
Three ICU Units in Egypt. Paper presented at the Open Forum Infectious
Diseases.
Elligsen, M., Walker, S. A., Pinto, R., Simor, A., Mubareka, S.,
Rachlis, A., . . . Daneman, N. (2012). Audit and feedback to reduce
broad-spectrum antibiotic use among intensive care unit patients a
controlled interrupted time series analysis. Infection Control &
Hospital Epidemiology, 33 (4), 354-361.
Hanberger, H., Skoog, G., Ternhag, A., & Giske, C. G. (2014).
Antibiotic consumption and antibiotic stewardship in Swedish hospitals.Upsala Journal of Medical Sciences, 119 (2), 154-161.
Hansen, D. S., Aucken, H. M., Abiola, T., & Podschun, R. (2004).
Recommended test panel for differentiation of Klebsiella species on the
basis of a trilateral interlaboratory evaluation of 18 biochemical
tests. Journal of clinical microbiology, 42 (8), 3665-3669.
Hidron, A. I., Edwards, J. R., Patel, J., Horan, T. C., Sievert, D. M.,
Pollock, D. A., . . . Facilities, P. N. H. S. N. (2008).
Antimicrobial‐resistant pathogens associated with healthcare‐associated
infections: annual summary of data reported to the National Healthcare
Safety Network at the Centers for Disease Control and Prevention,
2006–2007. Infection control and hospital epidemiology, 29 (11),
996-1011.
Horikoshi, Y., Suwa, J., Higuchi, H., Kaneko, T., Furuichi, M., Aizawa,
Y., . . . Shoji, T. (2017). Sustained pediatric antimicrobial
stewardship program with consultation to infectious diseases reduced
carbapenem resistance and infection-related mortality.International Journal of Infectious Diseases, 64 , 69-73.
In, C. (2018). Performance standards for antimicrobial susceptibility
testing: Wayne, PA: Clinical and Laboratory Standards Institute.
Jaggi, N., Sissodia, P., & Sharma, L. (2012). Impact of antimicrobial
stewardship programme on carbapenem resistance in gram negative isolates
in an Indian tertiary care hospital. American Journal of
Infectious Diseases, 8 (2), 106-111.
Khalifa, H. O., Soliman, A. M., Ahmed, A. M., Shimamoto, T., Nariya, H.,
Matsumoto, T., & Shimamoto, T. (2019). High prevalence of antimicrobial
resistance in gram-negative Bacteria isolated from clinical settings in
Egypt: recalling for judicious use of conventional antimicrobials in
developing nations. Microbial Drug Resistance, 25 (3), 371-385.
Lesprit, P., Landelle, C., & Brun-Buisson, C. (2013). Clinical impact
of unsolicited post-prescription antibiotic review in surgical and
medical wards: a randomized controlled trial. Clinical
microbiology and infection, 19 (2), E91-E97.
Lindsay, P. J., Rohailla, S., Taggart, L. R., Lightfoot, D., Havey, T.,
Daneman, N., . . . Muller, M. P. (2019). Antimicrobial stewardship and
intensive care unit mortality: a systematic review. Clinical
Infectious Diseases, 68 (5), 748-756.
Liu, J., Wang, H., Huang, Z., Tao, X., Li, J., Hu, Y., . . . Zou, M.
(2019). Risk factors and outcomes for carbapenem-resistant Klebsiella
pneumoniae bacteremia in onco-hematological patients. The Journal
of Infection in Developing Countries, 13 (05), 357-364.
Maeda, M., Takuma, T., Seki, H., Ugajin, K., Naito, Y., Yoshikawa, M., .
. . Shoji, H. (2016). Effect of interventions by an antimicrobial
stewardship team on clinical course and economic outcome in patients
with bloodstream infection. Journal of Infection and Chemotherapy,
22 (2), 90-95.
McNulty, C. A. (2012). European Antibiotic Awareness Day 2012: general
practitioners encouraged to TARGET antibiotics through guidance,
education and tools. Journal of antimicrobial chemotherapy,
67 (11), 2543-2546.
Melake, N. A., Mahmoud, A. B., Elraghy, N. A., Labib, A. Z., Hassan, D.
M., & Elbrolosy, A. M. (2016). Detection of Klebsiella pneumoniae
carbapenemases and metallo-β-lactamases among Klebsiella pneumoniae
isolates from hospitalized patients at Menoufia University Hospitals,
Egypt. Menoufia Medical Journal, 29 (4), 801.
Metwally, L., Gomaa, N., Attallah, M., & Kamel, N. (2013). High
prevalence of Klebsiella pneumoniae carbapenemase-mediated resistance in
K. pneumoniae isolates from Egypt. Eastern Mediterranean Health
Journal, 19 (11).
Nowak, M. A., Nelson, R. E., Breidenbach, J. L., Thompson, P. A., &
Carson, P. J. (2012). Clinical and economic outcomes of a prospective
antimicrobial stewardship program. American Journal of
Health-System Pharmacy, 69 (17), 1500-1508.
Prabaker, K., & Weinstein, R. A. (2011). Trends in antimicrobial
resistance in intensive care units in the United States. Current
opinion in critical care, 17 (5), 472-479.
Razali, N. M., & Wah, Y. B. (2011). Power comparisons of shapiro-wilk,
kolmogorov-smirnov, lilliefors and anderson-darling tests. Journal
of statistical modeling and analytics, 2 (1), 21-33.
Rimawi, R. H., Mazer, M. A., Siraj, D. S., Gooch, M., & Cook, P. P.
(2013). Impact of regular collaboration between infectious diseases and
critical care practitioners on antimicrobial utilization and patient
outcome. Critical care medicine, 41 (9), 2099-2107.
Shapiro, S. S., & Wilk, M. B. (1965). An analysis of variance test for
normality (complete samples). Biometrika, 52 (3/4), 591-611.
Sherry, N., & Howden, B. (2018). Emerging Gram negative resistance to
last-line antimicrobial agents fosfomycin, colistin and
ceftazidime-avibactam–epidemiology, laboratory detection and treatment
implications. Expert review of anti-infective therapy, 16 (4),
289-306.
Shorr, A. F., Zilberberg, M. D., Micek, S. T., & Kollef, M. H. (2014).
Predictors of hospital mortality among septic ICU patients with
Acinetobacter spp. bacteremia: a cohort study. BMC infectious
diseases, 14 (1), 572.
Shu, L.-b., Lu, Q., Sun, R.-h., Lin, L.-q., Sun, Q.-l., Hu, J., . . .
Zhang, R. (2019). Prevalence and phenotypic characterization of
carbapenem-resistant Klebsiella pneumoniae strains recovered from sputum
and fecal samples of ICU patients in Zhejiang Province, China.Infection and drug resistance, 12 , 11.
Simmons, M., Sherman, B., & Crosmun, C. (2016). Decrease in Daily
Defined Doses of Carbapenems Using Minimal Impact Interventions,
Suppression of Sensitivities and Utilization. Paper presented at the
Open Forum Infectious Diseases.
Sketris, I. S., Metge, C. J., Ross, J. L., MacCara, M. E., Comeau, D.
G., Kephart, G. C., & Blackburn, J. L. (2004). The use of the World
Health Organisation anatomical therapeutic chemical/defined daily dose
methodology in Canada. Drug information journal: DIJ/Drug
Information Association, 38 (1), 15-27.
Solomon, D. H., Van Houten, L., Glynn, R. J., Baden, L., Curtis, K.,
Schrager, H., & Avorn, J. (2001). Academic detailing to improve use of
broad-spectrum antibiotics at an academic medical center. Archives
of internal medicine, 161 (15), 1897-1902.
Solomon, S. L., & Oliver, K. B. (2014). Antibiotic resistance threats
in the United States: stepping back from the brink. American
family physician, 89 (12), 938-941.
Srinivasan, A. (2017). Antibiotic stewardship: why we must, how we can.Cleveland Clinic journal of medicine, 84 (9), 673.
Van De Sande-Bruinsma, N., Grundmann, H., Verloo, D., Tiemersma, E.,
Monen, J., Goossens, H., . . . System, E. A. R. S. (2008). Antimicrobial
drug use and resistance in Europe. Emerging infectious diseases,
14 (11), 1722.
Vincent, J.-L., Rello, J., Marshall, J., Silva, E., Anzueto, A., Martin,
C. D., . . . Sakr, Y. (2009). International study of the prevalence and
outcomes of infection in intensive care units. JAMA, 302 (21),
2323-2329.
Yong, M., Buising, K. L., Cheng, A., & Thursky, K. (2010). Improved
susceptibility of Gram-negative bacteria in an intensive care unit
following implementation of a computerized antibiotic decision support
system. Journal of Antimicrobial Chemotherapy, 65 (5), 1062-1069.
Yuan, Y., Wang, J., Yao, Z., Ma, B., Li, Y., Yan, W., . . . Xu, J.
(2020). Risk Factors for Carbapenem-Resistant Klebsiella pneumoniae
Bloodstream Infections and Outcomes. Infection and drug
resistance, 13 , 207.